Latest Ratings for SAGE
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Morgan Stanley | Maintains | Equal-Weight | |
| Mar 2022 | Truist Securities | Maintains | Hold | |
| Mar 2022 | Mizuho | Maintains | Neutral |
Where Sage Therapeutics Stands With Analysts
Where Today's News Shapes Tomorrow
